{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:36:42Z","timestamp":1790199402895,"version":"4.1.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Machine learning models have emerged as pivotal tools for enhancing the predictive accuracy of multidrug-resistant bacterial pneumonia (MDR-BP) risk in critically ill patients following neurosurgery procedures. By enabling early risk stratification, these models facilitate timely diagnosis and proactive therapeutic interventions. However, existing prediction frameworks exhibit limitations in elucidating the relative importance of risk factors, thereby impeding precise clinical decision-making and individualized patient management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the performance of six ensemble classification algorithms and three single classification algorithms in predicting MDR-BP risk factors among neurosurgical postoperative critically ill patients, identify the optimal predictive model, and determine key influential factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective study involving 750 neurosurgical patients admitted to a neurosurgery center at a tertiary hospital in Beijing between January 2020 and December 2023. Following rigorous data preprocessing, univariate analysis was performed to screen statistically significant variables. The Synthetic Minority Over-sampling Technique (SMOTE) was applied to address class imbalance. Predictive models for MDR-BP risk factors were constructed, and their performance was validated using 10-fold cross-validation to assess mean accuracy, recall, and specificity. The SHapley Additive exPlanations (SHAP) framework was employed to quantify feature importance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The Random Forest model demonstrated superior performance, achieving the highest mean accuracy (0.775) and AUC value (0.860) compared to other models. SHAP interpretation revealed three critical predictors of MDR-BP: intensive care unit length of stay (ICU-LOS), antibiotic treatment duration, and serum albumin level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The Random Forest algorithm demonstrates superior predictive accuracy for MDR-BP risk in critically ill post-neurosurgical patients. ICU-LOS, antibiotic treatment duration, and serum albumin level are significant predictors of MDR-BP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2025.1623968","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T01:25:51Z","timestamp":1750814751000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Development of a predictive model for risk factors of multidrug-resistant bacterial pneumonia in critically ill post-neurosurgical patients"],"prefix":"10.3389","volume":"13","author":[{"given":"Aixiang","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanni","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuewei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/B978-0-444-63600-3.00020-9","article-title":"Management of infections associated with neurocritical care","volume":"140","author":"Rivera-Lara","year":"2017","journal-title":"Handb Clin Neurol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/MCC.0000000000000526","article-title":"Microbial cause of ICU-acquired pneumonia: hospital-acquired pneumonia versus ventilator-associated pneumonia","volume":"24","author":"Luyt","year":"2018","journal-title":"Curr Opin Crit Care"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3109\/00365548","article-title":"Sulbactam treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex","volume":"47","author":"Lin","year":"2015","journal-title":"Infect Dis (Lond)"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s10072-021-05721-1","article-title":"A retrospective study on risk factors and disease burden for hospital-acquired pneumonia caused by multi-drug-resistant bacteria in patients with intracranial cerebral hemorrhage","volume":"43","author":"Yang","year":"2022","journal-title":"Neurol Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1055\/s-0037-1599225","article-title":"Infections due to Acinetobacter baumannii in the ICU: treatment options","volume":"38","author":"Lynch","year":"2017","journal-title":"Semin Respir Crit Care Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jhin.2011.05.007","article-title":"Identifying new risk factors for Pseudomonas aeruginosa pneumonia in intensive care units: experience of the French national surveillance, REA-RAISIN","volume":"79","author":"Venier","year":"2011","journal-title":"J Hosp Infect"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1445425","DOI":"10.3389\/fpubh.2024.1445425.eCollection2024","article-title":"Integrating deep learning in public health: a novel approach to PICC-RVT risk assessment","volume":"12","author":"Nie","year":"2025","journal-title":"Front Public Health"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12959-017-0155-z","article-title":"The diagnosis and treatment of venous thromboembolism in Asian patients","volume":"16","author":"Wang","year":"2018","journal-title":"Thromb J"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s11239-022-02693-7","article-title":"Development and validation of a prediction model of catheter-related thrombosis in patients with cancer undergoing chemotherapy based on ultrasonography results and clinical information","volume":"54","author":"Lin","year":"2022","journal-title":"J Thromb Thrombolysis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ijmedinf.2019.06.001","article-title":"Machine learning approaches for risk assessment of peripherally inserted central catheter-related vein thrombosis in hospitalized patients with cancer","volume":"129","author":"Liu","year":"2019","journal-title":"Int J Med Inform"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.jvsv.2020.12.075","article-title":"The Caprini thrombosis risk model predicts the risk of peripherally inserted central catheter-related upper extremity venous thrombosis in patients with cancer","volume":"9","author":"Lin","year":"2021","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"9871","DOI":"10.1038\/s41598-022-13916-5","article-title":"A clinical study of peripherally inserted central catheter-related venous thromboembolism in patients with hematological malignancies","volume":"12","author":"Yue","year":"2022","journal-title":"Sci Rep"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3760\/cma.j.issn.1001-0939","article-title":"Guidelines for diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in Chinese adults (2018 edition)","volume":"41","year":"2018","journal-title":"Chin J Tuberc Respir Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1093\/jac\/dkm088","article-title":"Modified guidelines impact on antibiotic use and costs: duration of treatment for pneumonia in a neurosurgical ICU is reduced","volume":"59","author":"Meyer","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"28S","DOI":"10.1378\/chest.115.suppl_1.28s","article-title":"Nosocomial pneumonia in the ICU--year 2000 and beyond","volume":"115","author":"Bowton","year":"1999","journal-title":"Chest"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1086\/511702","article-title":"Pathogens in early-onset and late-onset intensive care unit-acquired pneumonia","volume":"28","author":"Verhamme","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"47818","DOI":"10.1074\/jbc.M206404200","article-title":"An essential role for albumin in the interaction of endotoxin with lipopolysaccharide-binding protein and sCD14 and resultant cell activation","volume":"277","author":"Gioannini","year":"2002","journal-title":"J Biol Chem"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jhep.2014.04.012","article-title":"Human serum albumin, systemic inflammation, and cirrhosis","volume":"61","author":"Arroyo","year":"2014","journal-title":"J Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e0196655","DOI":"10.1371\/journal.pone.0196655","article-title":"Association between serum albumin level and incidence of end-stage renal disease in patients with immunoglobulin a nephropathy: a possible role of albumin as an antioxidant agent","volume":"13","author":"Kawai","year":"2018","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuint.2018.01.002","article-title":"Research progress in stroke-induced immunodepression syndrome (SIDS) and stroke-associated pneumonia (SAP)","volume":"114","author":"Liu","year":"2018","journal-title":"Neurochem Int"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1623968\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T01:25:52Z","timestamp":1750814752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1623968\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":23,"alternative-id":["10.3389\/fpubh.2025.1623968"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1623968","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"article-number":"1623968"}}